Status:
TERMINATED
Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
Lead Sponsor:
Washington University School of Medicine
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is very limited data on the utilization of National Cancer Institute Comprehensive Cancer Center (NCI-CCC) satellite sites in general. Of what is available, most is in regards to providing chemo...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- At least 18 years old
- Diagnosed with multiple myeloma
- Receiving care from a provider within the Division of Oncology at the primary Siteman Cancer Center site
- Resides within the catchment area of a Siteman Cancer Center satellite site
- Able to read, speak, and understand English
- Willing to provide informed consent
Exclusion
Key Trial Info
Start Date :
September 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2024
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT05971056
Start Date
September 8 2023
End Date
March 22 2024
Last Update
October 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110